FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to ophthalmology, and is intended for the treatment of keratoconus and other degenerative diseases of the cornea. Drug for the treatment of keratoconus and other degenerative diseases of the cornea contains, as an active component, providing therapeutic crosslinking, an effective amount of a primary or secondary amine with functional groups in the form of a salt or as part of a transition metal complex compound or a mixture thereof.
EFFECT: use of the invention allows to increase the effectiveness of the treatment of keratoconus and other degenerative diseases of the cornea by improving the nutrition of the cornea and increasing its elastic-strength characteristics.
21 cl, 4 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF PROGRESSIVE MYOPIA | 2013 |
|
RU2635185C2 |
DRAIN FOR SURGICAL TREATMENT OF GLAUCOMA AND METHOD FOR OBTAINING IT | 2018 |
|
RU2771784C2 |
OPHTHALMIC CROSS-LINKING AGENT-2 | 2012 |
|
RU2475248C1 |
METHOD OF PREPARING AN ANTIGLAUCOMATOUS DRAINAGE WITH ANTIPROLIFERATIVE PROPERTIES | 2022 |
|
RU2796427C1 |
METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
CROSS-LINKING OPHTHALMIC AGENT | 2009 |
|
RU2412707C1 |
OPHTHALMIC SOLUTION FOR UV-A RAYS PROTECTION OF INTERNAL STRUCTURES OF EYEBALL OR FOR TREATING KERATOCONUS BY TRANSEPITHELIAL CROSSLINKING | 2010 |
|
RU2540481C2 |
SALT, PRODUCED FROM AMINE AND CARBOSTYRIL DERIVATIVE | 2005 |
|
RU2372336C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING EYE DISEASES ACCOMPANIED BY OXIDATIVE STRESS, AND A METHOD FOR USE THEREOF | 2018 |
|
RU2694226C1 |
DEXAMETHASONE CONJUGATE WITH SYNTHETIC STATISTICAL POLYPEPTIDE | 2020 |
|
RU2792146C2 |
Authors
Dates
2019-04-01—Published
2013-06-18—Filed